BlackRock Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $100K | Buy |
9,346
+346
| +4% | +$3.7K | ﹤0.01% | 2965 |
|
|
2016
Q3 | $97K | Buy |
9,000
+1,697
| +23% | +$18.3K | ﹤0.01% | 2967 |
|
|
2016
Q2 | $49K | Hold |
7,303
| – | – | ﹤0.01% | 3176 |
|
|
2016
Q1 | $34K | Sell |
7,303
-348
| -5% | -$1.62K | ﹤0.01% | 3228 |
|
|
2015
Q4 | $48K | Sell |
7,651
-3,335
| -30% | -$20.9K | ﹤0.01% | 3158 |
|
|
2015
Q3 | $97K | Sell |
10,986
-11,683
| -52% | -$103K | ﹤0.01% | 3073 |
|
|
2015
Q2 | $267K | Buy |
22,669
+14,290
| +171% | +$168K | ﹤0.01% | 2584 |
|
|
2015
Q1 | $121K | Buy |
8,379
+2,727
| +48% | +$39.4K | ﹤0.01% | 2923 |
|
|
2014
Q4 | $96K | Sell |
5,652
-14,672
| -72% | -$249K | ﹤0.01% | 3031 |
|
|
2014
Q3 | $253K | Hold |
20,324
| – | – | ﹤0.01% | 2432 |
|
|
2014
Q2 | $298K | Buy |
20,324
+572
| +3% | +$8.39K | ﹤0.01% | 2357 |
|
|
2014
Q1 | $402K | Sell |
19,752
-3,603
| -15% | -$73.3K | ﹤0.01% | 2182 |
|
|
2013
Q4 | $458K | Buy |
23,355
+7,771
| +50% | +$152K | ﹤0.01% | 2076 |
|
|
2013
Q3 | $706K | Buy |
15,584
+11,446
| +277% | +$519K | ﹤0.01% | 1648 |
|
|
2013
Q2 | $99K | Buy |
+4,138
| New | +$99K | ﹤0.01% | 2904 |
|